Northwest Biotherapeutics: Q3 Earnings Snapshot

BETHESDA, Md. (AP) _ Northwest Biotherapeutics Inc. (NWBO) on Wednesday reported a loss of $32.9 million in its third quarter.

On a per-share basis, the Bethesda, Maryland-based company said it had a loss of 3 cents.

The cancer drug developer posted revenue of $206,000 in the period.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on NWBO at

Copyright © 2022 . All rights reserved. This website is not intended for users located within the European Economic Area.